logo

411%

In 19 Months

logo

348%

In 19 Months

logo

288%

In 18 Months

logo

269%

In 7 Months

logo

238%

In 15 Months

logo

237%

In 17 Months

Invest Smart,
Invest Wise

Introducing MILARS® - A successful investment strategy to build growth portfolio.

Build Your Portfolio for Growth

arrow
arrow

Investing in high-growth stocks has been a proven strategy for building wealth.

Introducing MILARS®: Our Winning Strategy

MILARS® (Market direction, Industries & sectors, Leading stocks, Acceleration in earnings,
Relative price strength, Selling Rules) is more than just a strategy;
it's the secret behind our smart stock choices arrow

Research Reports

Explore our in-depth research on growth stocks

Company Date of Publication Price Close Price Report Link
May 24, 2024 258.00 628.75
February 02, 2024 Feb 02, 2024 6298.45 8765.00
January 08, 2024 Jan 08, 2024 1197.00 2670.85
June 05, 2024 Jun 05, 2024 9180.00 11300.00
May 09, 2024 372.00 674.90
April 03, 2024 Apr 03, 2024 387.30 542.00
February 27, 2024 Feb 27, 2024 762.00 1303.70
June 26, 2024 Jun 26, 2024 449.75 653.90
January 04, 2024 Jan 04, 2024 1408.00 2015.85
August 22, 2024 Aug 22, 2024 222.24 308.30

Why MILARS®?

Proven Strategy
Proven strategy

MILARS® (Market direction, Industries & sectors, Leading stocks, Acceleration in earnings, Relative price strength, Selling Rules) is our comprehensive approach to stock selection.

Consistent Performance
Consistent performance

stockaxis flagship's MILARS® strategy has a track record of delivering robust performance.

Selling Rules
Predefined selling rules

We understand the importance of timing when it comes to optimizing profits. That's why we follow predefined selling rules, including cutting losses short and letting winners run.

Active Tracking
Active tracking

At stockaxis, our work doesn't stop at the initial recommendation. Our team actively monitors the recommended stocks, including price movements, financial performance, and company updates.

arrow Fast and simple subscription process

add stocks

01

Select your service

Choose the service that aligns
with your preferences.

add stocks
sign up sign up

02

Fill-up your details

Complete the subscription process
by providing your information.

receive alerts

03

Start receiving alerts

You're all set to begin receiving
real-time recommendations.

receive alerts

Experience matters: Take a premium trial

Start your 14-day premium trial at Rs. 499

Rs. 199


What you'll get:
  • 5 High-Quality Growth Stocks.
  • Research Reports and updates.
  • Stock Alerts via WhatsApp, e-mails & App notification.
  • Access to Research Analysts.

100% refund promise—if you’re not happy, we’ll return your money!

arrow

Start here

Full name
Mobile number You will receive the recommendation via WhatsApp
Email ID You will receive the research reports via Email

Next step: After successful payment, you'll be prompted to provide your PAN as mandated by SEBI guidelines for availing services from a SEBI registered entity.

During the premium trial, you can expect the following:

Access to Research
Access to Research

Gain access to meticulously researched stock recommendations and analysis.

Smart Investment
Smart Investment Opportunities

Receive stock recommendations based on the proven MILARS® strategy.

Real-time Alerts
Real-time Alerts

Get alerts for buying and selling opportunities via WhatsApp, e-mails and mobile app notifications.

Dedicated Support
Dedicated Support

Enjoy exceptional client support to assist you throughout your premium trial period.

Access Anywhere
Access Anywhere

Effortlessly access recommended stocks through the user-friendly web login and mobile app.

Insightful Guidance
Insightful Guidance

Receive entry and exit guidance for investments, with diligent tracking of open positions.

Low-Risk Trial
Low-Risk Premium Trial

Explore the premium subscription for 14 days at a reduced cost of only Rs. 199.

Trial Package
Comprehensive Premium Trial Package

The premium trial includes high-quality growth stocks, research reports, stock alerts, and a dedicated relationship manager.

No Commitment
No Commitment

There's no long-term commitment required, making it a low-risk way to experience stockaxis' services.

Gain access to meticulously researched stock recommendations and analysis.

Receive stock recommendations based on the proven MILARS® strategy.

Get alerts for buying and selling opportunities via WhatsApp, e-mails and mobile app notifications.

Enjoy exceptional client support to assist you throughout your premium trial period.

Effortlessly access recommended stocks through the user-friendly web login and mobile app.

Receive entry and exit guidance for investments, with diligent tracking of open positions.

Explore the premium subscription for 14 days at a reduced cost of only Rs. 199.

The premium trial includes high-quality growth stocks, research reports, stock alerts, and a dedicated relationship manager.

There's no long-term commitment required, making it a low-risk way to experience stockaxis' services.

stockaxis Reviews: In Their Own Words.

Google review: Our client heart stockaxisarrow

1 / 10

“This rating is for becoming a member of Stockaxis family. Will be able to provide you feedback only once I experience the journey of investment with you all. Regards.”

5.0

star Sunil Palo - a day ago

“Very Professional company, Mr. sandeep is very prompt and very professional in his job, explained well everything in detail and understood my investment objective. Now my next review will be on performance parameters.”

5.0

star Amit Prasad - a day ago

“Mr. Mahesh Pawar is backing & guiding me to get profitable trade They are really technically sound”

5.0

star Rajesh - a day ago

“Great experience with my RM... she is weel talented and knowledgeable person and I m very well satisfied with her..... thank you RM for your full support..... 🙏🙏”

5.0

star Lalit Bhatt - a week ago

“Very nice research/ stock advice with entry & exits at the proper price. It has improved a lot during the last one year. I am really satisfied.”

5.0

star DK JAIN - 2 weeks ago

Got questions?
We have answers.

Who can offer Equity Research Services?

Equity Research Services can be offered only by entities registered with SEBI under the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. We have registered with SEBI, the regulatory authority for the securities market in India. Our registration number is INH000007669.

How does this service work?

With stockaxis Services, you get to know what to buy, when to buy & why to buy. All you have to do is execute the trades once you receive our recommendations & then watch your equity portfolio grow.

How will I receive the recommendations?

You shall receive the recommendations on a real-time basis via WhatsApp, e-mails & App notification.

What if I have queries?

Fret not! You shall be allotted a Relationship Manager who shall accompany you on your investment journey with stockaxis & will ensure that all your queries are answered.

What information is needed for activating the service?

  • PAN (Permanent Account Number)
  • Address
  • Date of Birth

What type of stock recommendations does stockaxis provide?

stockaxis provides diverse recommendations, including mid-cap, large-cap, and small-cap stocks, selected using our in-depth research.

100% refund promise—if you’re not happy!

Rs.199 Rs.499

Offer end in

PG Electroplast Ltd.

Consumer Durables - Domestic Appliances


Stock Info
  • BSE 533581
  • NSE PGEL
  • Face Value (Rs) 10
  • Equity Capital (Rs cr) 26
  • Mkt Cap (Rs cr) 6,484.14
  • 52w H/L (Rs) 2640.00 - 1446.00
Shareholding pattern
  • (as on 31-Mar) %
  • Promoter 53.70
  • FIIs 11.02
  • DII 10.94
  • Public & Others 24.33
Published Date May 24, 2024
Current Market Price Rs. 258.00
Rating Buy

PGEL Buy

PG Electroplast Ltd.

Rs. 258.00

May 24, 2024

BSE 533581
52W high 2640.00
52W low 1446.00
Face Value Rs.10
Return (%) 1m 3m 12m
Absolute 23.42 35.60 70.66
Sensex 2.28 3.11 21.68
PG Electroplast Ltd Sensex

Strong Growth in Q4; Healthy outlook

Company Profile

PG Electroplast Limited (PGEL) is the flagship company of PG Group, which had started its journey in 1977. PG Electroplast, formally set up in 2003, and is a leading, diversified Indian Electronic Manufacturing Services provider.PGEL specializes in Original Design Manufacturing (ODM), Original Equipment Manufacturing (OEM) and Plastic Injection Moulding, providing One Stop Solutions to 70+ leading Indian and Global brands. It manufactures a comprehensive range of consumer electroniccomponents and finished products such as colour television (CTV) sets & components, air conditioners (ACs) sub-assemblies, DVD players, water purifiers and Compact Fluorescent Lamps (CFL) for thirdparties.As backward integration, it also manufactures plastic injection moulding and manufacturePrinted Circuit Boards (PCB) assemblies for CTVs, DVD players and CFL. PG has 11 manufacturing units in Greater Noida (UP), Ahmednagar (MH), Bhiwadi (RJ) and Roorkee (UK). The company caters to industries such as automotivecomponents, consumer electronics mobile handsets and sanitaryware.

PGEL specializes in Original Design Manufacturing (ODM), Original Equipment Manufacturing (OEM) andPlastic Injection Moulding, catering to 50+ leading Indian and Global brands. PG Technoplast Private Limited (PGTL) is a wholly owned subsidiary of PG Electroplast which is engaged in the business ofmanufacturing Room Air Conditioners and various components for the Consumer Durables andConsumer Electronics industries. The business verticals in which company operates is showcased below.

PGEL
Investment Arguments

Established market position: The group is one of the leading contract manufacturers/vendors for air conditioners (ACs), washing machines and otherplastic moulding components for white goods the plastic components segment. The promoters’ experience of more than 30 years in the consumer durables industry, the group's established position and their healthy relationships with customers will continue to support the business. PGEL has the capacity to offer product development and manufacturing solutions from designing, tooling to final assembling and testing. Most of the operations are backward-integrated and the processes are carried out in-house. Backward integration gives it the flexibility to control the manufacturing processes and reduce dependence on external suppliers, which has enabled it to become a consistent and reliable ODM supplier and contract manufacturer.

Long – standing relationship with marquee customers: The group supplies to leading brands such as LG electronicsIndia Pvt Ltd, Whirlpool India Ltd, Voltas, Sansui, Honeywell, Hyundai, Daikin, Godrej, Blue Star, Astral etc. It supplies to all the leading players in the washing machine and domestic refrigeration and air conditioning (RAC) market. The group has large product portfolio manufacturing plastic parts for a comprehensive range of consumer electronic products such as air conditioners (ACs), air Coolers, refrigerators and washing machines. PGEL is one of the leading, diversified Indian manufacturing services provider and among the few companies in India specialising in ODM, OEM and plastic injection moulding for the consumer durables industry, thereby providing one stop and end to end solutions to consumer durable brands.

Strong Industry Tailwinds: The Rapid rate of urbanization, growth of young population with rising income levels is leading to largeemerging middle class in India Implying huge potential demand for the consumer appliance and durablemarket in coming years. Low penetration levels, falling prices of durables and electronics and changinglifestyle of the Indian consumer are expected to remain big demand drivers for the consumer durable and electronics Industry in India in near future. Government reforms such as Digital India, Make in India, Power for all and Jan Dhan-Aadhar Mobile Trinity are providing fresh impetus to the Consumerappliance and durable Industry. Further the Government’s initiatives of promoting electronicmanufacturing and treating the industry as one of the key pillars of the Digital India Program, opens newand exciting opportunities for the Industry. The Management is enthused about the overall opportunitysize and anticipates high growth rates in the industry segments where, company has presence.

Q4FY24 Financial Performance: PGEL showcased remarkable earnings growth for the quarter ended Q4FY24 driven by growth across all its key business segments. Consolidated net sales rose 30% YoY to Rs.1077 cr as compared to Rs.827 cr registered in the same quarter of corresponding fiscal. On the operational front, consolidated EBITDA witnessed a growth of 56% YoY to Rs.120 cr. EBITDA Margin expanded by 180 bps at 11.1% YoY. PAT surged 78% YoY to Rs.72 cr led by solid topline growth and robust operational performance.

Other Key Developments:

  • FY2024 has been strong growth period as Consolidated Revenues grew 27.2% and closed at INR 2746.50 crores for the company. This is despite the ASPs falling sharply across the board for all our product categories.
  • The Product business contributed 60.7% of the total revenues in FY24. Room AC business at Rs.1,317 crores grew 26% during the period while the Washing Machines business had a growth of 20% YoY.
  • PGEL’s 100% subsidiary, PG Technoplast, crossed Rs.1,456 crores in revenue in its third year of operations. Company’s Bhiwadi AC Unit became operational during the year.
  • Order book for product business remains robust and the company hopes to accelerate the product business growth in FY2025.
  • During the quarter and Financial year, operating margins have improved QoQ and YoY due cost control, softer commodity prices and operating leverage.
  • Net debt has decreased by almost Rs.325 crores in FY24 despite Capex and acquisition of NGM. The operating cash flow during the year has been strong and working capital optimisation remains key focus area for the company.
  • Company is seeing increased interest for business from new and existing clients, and we remain very confident on the future growth prospects of the business.
  • For FY25, creating building blocks for next level of growth and improving capital efficiency will be the major priorities. R&D, New Product Development and Capacity Enhancement are the focus areas for future across product businesses. Company plans to strengthen its product offerings further in both AC and WMs.

Key Conference call takeaways:

  • For PGEL, Management has guided for consolidated revenues of Rs.3400 cr, which is a growth of 24% YoY over FY24 revenues of Rs.2,746 cr despite TV business revenues shifting to JV company Goodworth Electronics Ltd.
  • Management expects Goodworth revenues to be at Rs.600 cr.
  • Implying Group Revenues is pegged at Rs.4000 cr
  • PGEL Net profit guidance is pegged at Rs.200 cr which is a growth of 46% over FY24 Net profit of Rs.137 cr.
  • In FY2025, Management expects EBITDA margins to have slight upward bias.
  • The growth in product business i.e., WM, RAC and Coolers is expected to be around 44% to over INR 2400 crores from INR 1668 crores in FY2024.
  • Capex for FY2025 will be in the range of 350-370 crores. New Integrated Unit for Manufacturing RAC in Rajasthan, New Building in Greater Noida and new building along with further AC capacity expansion in Supa is being planned.

Apar Industries Ltd

Electric Equipment


Stock Info
  • BSE 532259
  • NSE APARINDS
  • Face Value (Rs) 10
  • Equity Capital (Rs cr) 38
  • Mkt Cap (Rs cr) 25,309.25
  • 52w H/L (Rs) 6450.00 - 1885.00
Shareholding pattern
  • (as on 31-Dec) %
  • Promoter 57.77
  • FIIs 10.98
  • DII 18.62
  • Public & Others 12.63
Published Date February 02, 2024
Current Market Price Rs. 6298.45
Rating Buy

APARINDS Buy

Apar Industries Ltd.

Rs. 6298.45

Feb 02, 2024

BSE 532259
52W high 6450.00
52W low 1885.00
Face Value Rs.10
Return (%) 1m 3m 12m
Absolute 4.09 24.74 224.47
Sensex -0.87 12.67 19.99
Apar Industries Ltd Sensex

Healthy Q3 Earnings; enough levers in place to sustain growth

Company Profile

Founded by Dharmsinh D. Desai in 1958, APAR Industries (APAR) is engaged in three broad business segments-transformer oils and specialty oils (TSO), conductors’ segment, and power/telecom cables. Apart from being a market leader in India, the company has a global presence, exporting to over 140 countries. APAR has total installed capacity of 542,000 KL of transformer oils and 180,000 MT of conductors as on March 31, 2023. Its manufacturing facilities are located at Rabale (Maharashtra), Silvassa, Athola and Rakholi (Dadra and Nagar Haveli), Umbergaon and Khatalwad (Gujarat), Jharsugoda and Lapanga (Orissa), and Hamriyah (Sharjah). Furthermore, APAR has commissioned the continuously transposed conductor’s facility, a value-added product, with total installed capacity of 7000 MT for supply of copper conductors to transformer industry.

Conductors In conductors’ segment,APAR is one of the largest manufacturers in India with expertise in aluminium alloyrod and conductors. The company supplies its conductors to all top 25 global turnkey operators. New Productlaunched involves copper conductor for Railways, Optical Ground Wire, CTC for the transformerindustry.

PGEL

Cables: APAR is the largest domestic player in renewables. The company is India’s largest and most innovative supplier to thenuclear power, defence, and railways. It has widest range of medium-voltage & low-voltage XLPE cables,elastomeric cables, fibre optic cables and specialty cables.

Apar Industries

Specialty Oils & Lubricants: Apar Industry is the 3rd largest in transformer Oils globally. They have expertise in transformer oils in Indiawith 60% market share in power transformer. It is a leading supplier to tractor OEMs such as TAFE,Eicher, and Escorts. Products offered include Transformer oil, White Oils, Industrial, process oils,Industrial & auto lubricants, and petroleum Jelly. Its transformer oil is used in dielectric cooling, technicalgrade white oil is used in textile industry and incense perfume whereas the pharmaceutical grade whiteoils is used cosmetic and personal care products.Their lubricants product range include Automotive Lubricants and Industrial Lubricants.

Apar Industries
Investment Arguments

Well-established market position across segments: APAR is amongst the top three producers of conductors and speciality oils in the world. In the transformer oil segment, it has a product offering of over 500+ grades with varied application in the industrial oil sub segment. To cater to the need of growing demand in Middle East and African markets, APAR commissioned its port-based plant at Hamriyah, Sharjah in FY18. It has also entered into a brand and manufacturing alliance for its automotive lubricant segment with the global energy leader, ENI S.P.A, Italy.

Reputed clientele comprising large EPC players and major utilities like railways, defence and marine: The company has established relations with large EPC players like KalpataruPower Transmission Limited, L&T, KEC International Limited among others, along with the supply of conductorsand cables to all the transmission companies and major utilities like railways, defence and marine. The company is thelargest supplier of copper conductors for the railway electrification programme. In specialty oil, the company is one of the largest transformer oil manufacturers. It benefits from the strong demand for power transformers, while catering to other productslike white oil for food and pharma grade, industrial oil, and lubricants. We expect healthy demand from the power and infrastructure sectors,going forward.

Diversified revenue profile: APAR’s business segments comprise conductors, TSO, and cables. The conductor segment contributed 47% as of Q3FY24, TSO segment contributed 30% in Q3FY24 (PY: 36%), and the balance 22.7% was from the cables segment. APAR has incremental income coming from high-margin product for the conductor segment, which has increased the segment’s revenue by 67% in FY23. Similarly, the revenue from cables also increased by 64% led by higher sale of optical fibre cable (OFC). The total order stood at ₹6,081 crores with 40.1% share from premium products. Export contributes 48% of total order book. Order inflow for the conductor division stood at Rs.1896 crs, and ₹1,124 crore for the cables division as on December 31, 2023.

One of the largest players in the conductor segment: APAR is one of the largest companies, engaged in the manufacturing of TSO and Transmission & Distribution Overhead Conductors with a total installed capacity of 542,000 KL and 180,000 MT, respectively, as on March 31, 2023. In the conductor division, APAR caters to prominent customers like Power Grid Corporation of India Limited, various state government entities, Larsen &Toubro Limited, and prominent turnkey operators with whom it has a long-standing relationship. APAR also exports to major geographies with focus on Australia, Southeast Asia, Middle East, Latin America, North America, and Africa among others and has presence in more than 140 countries.

Q3FY24 Financial Performance: Apar Industries displayed a steady earnings performance for the quarter ended Q3FY24. Consolidated Net sales for the company improved marginally by 2% to Rs 3991 Cr as against Rs 3917 Cr as compared to the same quarter of the previous year, this was on account of de-inventory by US customers, however strongdomestic demand have partly offset the drop in US volumes,accordingly global sales ex-US grew by 17.2% YoY. On the operational front, consolidated EBITDA witnessed a strong growth of 22% YoY to Rs.426 cron the back of higher margins in oil business and low base in last year.Consolidated EBITDA increased by 24% to Rs 432 with EBITDA margin expanding by 190bps led by operating leverage, as well as higher margins in oil business. It continued its double-digit EBITDA margin for the quarterEBIT grew by 23% YoY to Rs.397 cr. Net profit surged 28% YoY to Rs.218 cr aided by healthy operational performance. Export mix at 39.0% versus 50.2% in LY Q3.

Conductors contributed the most 47.4% to thetotal revenue followed by Transformer& Speciality Oils and then Power, Telecom Cables.Conductor business continues to record high EBIDTA post forex at INR 41,530 per MT on the back of premiumisation. Cable business continued double digit EBITDA post forex margin at 11.5%. Oil business recorded EBITDA post forex at INR 8,157 per KL. Profitability for the quarter was higher, in part due to delay in shipments of base oils, resulting in a lower weighted average cost of inventory which will increase in Q4.

Conductors segment: Revenue up 4% YoY; volume up 14% v/s LY. Global sales ex-US grew by 28.3%. Domestic deliveries of aluminium & HTLS conductors, Rods was in good demand. Exports mix at 40.2% to revenues v/s 49.6% LY. EBITDA per MT at INR 41,530, at high levels on the back of premiumisation and exports. o EBDTAper MT INR 30,767. New order inflow of INR 1,896 crores.

Speciality Oils & Lubricants: Revenue is flattish on YoY basis. Volume is up 8% YoY. Export contributed 44.3% to revenue v/s 44.9% in LY Q3. Global Transformer oil volume up 16% v/s Q3 LY. o EBITDA post forex adjustment* was at INR 8,157 per KL which is up 396% on the back of better pricing in current quarter and low margin profile in last year. o Profitability for the quarter was higher, in part due to delay in shipments of base oils, resulting in a lower weighted average cost of inventory which will increase in Q4. EBDTA per KL INR 6,401.

Lubricants: Revenue is up by 18% in Q3 FY24 vs Q3 FY23. Industrial volume is down 5% YoY, Automotive volume is up by 10% YoY.

Cables: Revenue is flattish on YoY due to high base of US sales in LY. Global sales ex- US up 24.1%. Exports contribute 30.6% of sales in Q3 FY24 versus 60.1% in Q3 FY23. Low Exports due to de-inventorisation by US customers. EBITDA, post forex adjustment continues to sustain double-digit margin at 11.5% v/s 11.8% in LY. Robust order book at INR 1,124 crore. The US & EU enquiry levels have increased.

Netweb Technologies India Ltd

IT - Hardware


Stock Info
  • BSE 543945
  • NSE NETWEB
  • Face Value (Rs) 2
  • Equity Capital (Rs cr) 11
  • Mkt Cap (Rs cr) 6,668.93
  • 52w H/L (Rs) 1308.90 - 738.60
Shareholding pattern
  • (as on 30-Sep) %
  • Promoter 75.45
  • FIIs 10.33
  • DII 7.46
  • Public & Others 6.77
Published Date January 08, 2024
Current Market Price Rs. 1197.00
Rating Buy

NETWEB Buy

Netweb Tech India Ltd

Rs. 1197.00

Jan 08, 2024

BSE 543945
52W high 1308.90
52W low 738.60
Face Value Rs.2
Return (%) 1m 3m 12m
Absolute 23.10 44.09 -
Sensex 3.94 9.74 19.34
Netweb Technologies India Ltd Sensex

Leverage its presence in the fast-growing HCS (High end Computing Solutions) industry

Company Profile

Netweb Technologies India Ltd (NTIL) is one of India’s leading High-end Computing Solutions (HCS) providers, with fully integrated design and manufacturing capabilities. Their HCS offerings comprises (i) high performance computing (Supercomputing / HPC) systems; (ii) private cloud and hyper converged infrastructure (HCI); (iii) AI systems and enterprise workstations; (iv) high performance storage (HPS / Enterprise Storage System) solutions; (v) data centre servers; and (vi) software and services for their HCS offerings. NetWeb Technologies is one of India’s leading Indian origin owned and controlled OEM in the space of HCS providing Supercomputing systems, private cloud and HCI, data centre servers, AI systems and enterprise workstations, and HPS solutions.

In terms of number of HPC installations, they are one of the most significant OEMs in India amongst others. Since the inception of the erstwhile sole proprietorship, one of their Promoters, Sanjay Lodha, M/s Netweb Technologies, which the company had acquired in August, 2016, until February 28, 2023, they have undertaken installations of (i) over 300 Supercomputing systems, (ii) over 50 private cloud and HCI installations; (iii) over 4,000 accelerator / GPU based AI systems and enterprise workstations; and (iv) HPS solutions with throughput storage of up to 450 GB/ sec.

Company’s products and solutions offerings are sold under Tyrone brand and supported by engineering solutions.

netweb products
netweb products
netweb products
Investment Arguments

One of the India’s leading Indian OEM for HCS with integrated design and manufacturing capabilities Netweb Technologies Ltd is one of India’s leading OEM for HCS with integrated design and manufacturing capabilities. They design, manufacture and deploy HCS comprising proprietary middleware solutions, end user utilities and pre-compiled application stack. The proprietary designs are cloud native which, in addition to technological benefits, are capable of catering to the evolving needs of Customers. They are one of the few players in India who can offer a full stack of product and solution suite with comprehensive capabilities in designing, developing, implementing and integrating high performance computing solutions. They are also an Indian origin OEM to build Supercomputing systems, private cloud and HCI, data centre servers, AI systems and enterprise workstations, and HPS solutions under the ‘Make in India’ initiative of the Government of India.

Established strong relationships with marquee customers and diverse customer base. Netweb Technologies ability to provide end-to-end solutions right from design and development to implementation and service support enables it to procure repeat orders from existing clients and attract new clients. Their diverse customer base spread across different Application Industries demonstrates the suitability of systems, design and architecture across disparate applications. They cater to various end user industries such as information technology enabled services, entertainment and media, banking, financial services and insurance (BFSI), national data centres and government entities including in the defence sector, education and research development institutions (Application Industries) such as Indian Institute of Technology (IIT) Jammu, IIT Kanpur, NMDC Data Centre Private Limited (NMDC Data Centre), Airamatrix Private Limited (Airamatrix), Graviton Research Capital LLP (Graviton), Institute of Nano Science and Technology (INST), HL Mando Softtech India Private Limited (HL Mando), Dr. Shyam Prasad Mukherjee International Institute of Information Technology, Naya Raipur (IIIT Naya Raipur), Jawaharlal Nehru University (JNU), Hemvati Nandan Bahuguna Garhwal University (Hemvati University), Akamai India Networks Private Limited (Akamai), A.P.T. Portfolio Private Limited (A.P.T.), and Yotta Data Services Private Limited (Yotta), Centre for Computational Biology and Bioinformatics, Central University of Himachal Pradesh (CUHP University). It also caters to an Indian Government space research organisation and an R&D organisation of the Ministry of Electronics and Information Technology, Government of India which is involved in carrying out R&D in information technology and electronics and associated areas including Supercomputing.

Significant product development and innovation through R&D The company strives towards innovation in product range and have continued to build R&D capabilities by continuously developing R&D team to improve systems design and architecture and to expand products and solutions suite. R&D team is led by Mukesh Golla, Chief R&D Officer and has 38 members team. R&D team’s in-depth understanding of high-end computing solutions, their ability to meet the advanced technological challenges and their constant efforts at innovation, coupled with experience in working on innovative products in India, enables the company to stay at the forefront of technological evolution and anticipate and envision the future needs of our Customers and the market. The R&D Facilities have enabled the Company to increase the product lines to 8 viz., Tyrone Cluster Manager, KUBYTS, VERTA, ParallelStor, Collectivo, SKYLUS and Tyrone Camarero AI Systems and GPU System. Netweb Technologies along with various technology partners design and innovates products and provide services tailored to specific customer requirements. It also independently designs and innovates products and solutions offerings and provides services tailored to specific customer requirements.

Operates in a rapidly evolving and technologically advanced industry with high entry barriers. The rapidity of technological advancement necessitates continual innovation, improvement, and customisation of our solutions. Modification of designs and changes in implementation of the offerings requires technical skill set and expertise which is a significant entry barrier in the industry for new entrants. With continuous innovation, the company has developed a huge product basket comprising of kernel level design (i.e., establishes complete and unrestricted access between software and the underlying hardware) and development capabilities, hardware product designs, fine-tuned printed circuit board layouts, optimized operating systems, dense architectures, mix workload capabilities, deploying servers and a repository of HPC-AI codes.

Expanding and augmenting product portfolio Netweb Tech proposes to set up a manufacturing facility for setting up SMT line (surface mount technology) to eliminate reliance on third party for the purpose of manufacturing server motherboards and related printed circuit board (PCB) assemblies for its products. It proposes to continue to expand product portfolio by offering 5G and private 5G solutions and Network Switches, particularly having focus on the BFSI segment which is expected to emerge as the largest industry vertical for enterprise networking in India by 2027. The company have already forayed into this market and received approval to participate in and seek production linked incentives under, the Telecom and Networking PLI Scheme under the category of manufacturing of switches, 5G edge and enterprise equipment, and 5G RAN equipment. It proposes to also expand portfolio to include reduced instruction set computer architecture based HCS systems.

Q2FY24 Financial Performance Netweb Technologies reported healthy earnings growth for the quarter ended Q2FY24. Consolidated net sales saw a significant jump of 97% YoY to Rs.145 cr as against Rs.74 cr registered in the same quarter of corresponding fiscal. Gross Profit jumped 71% YoY to Rs.39 cr. Gross Profit Margin contracted 400 bps to 27% YoY. Operating EBITDA increased by 44% YoY to 19 cr in Q2FY24. Operating EBITDA margins for the quarter contracted by 488 basis points YoY at 13.3% due to higher input cost. Profit after tax for the quarter increased by 66% YoY basis reaching to 15 cr and PAT margin for the quarter was at 10.2% aided by healthy topline growth and robust operational performance.

Management highlighted EBITDA margins to be in the range of 14 to 15% due to operating leverage which will come into play.

PTCIL Industries (India) Ltd

Castings / Forgings


Stock Info
  • BSE 539006
  • NSE PTCIL
  • Face Value (Rs) 10
  • Equity Capital (Rs cr) 14
  • Mkt Cap (Rs cr) 11,871.91
  • 52w H/L (Rs) 10174.85 - 2950.00
Shareholding pattern
  • (as on 31-Mar) %
  • Promoter 62.95
  • FIIs 3.82
  • DII 0.44
  • Public & Others 32.79
Published Date June 05, 2024
Current Market Price Rs. 9180.00
Rating Buy

PTCIL Buy

PTCIL IND (India) LTD.

Rs. 9180.00

Jun 05, 2024

BSE 539006
52W high 10174.85
52W low 2950.00
Face Value Rs.10
Return (%) 1m 3m 12m
Absolute 10.75 -1.57 222.26
Sensex -2.46 -2.43 14.80
PTCIL Industries (India) Ltd Sensex

Multiple levers in place to drive growth

Company Profile

Incorporated in 1963, PTC Industries Ltd is engaged in the manufacturing of high-quality engineering components of steel and titanium castings for various critical and super-critical applications in the defence sector and medical equipment industry, among others. PTC has a wholly owned subsidiary, ATL, engaged in titanium castings manufacturing. The company uses various indigenously developed technologies like Centrifugal Castings, Replicast, RapidCast, forgeCAST & Titanium Powder for casting. The company caters to Oil & Gas, Aerospace, Marine, Pulp & Paper, Petrochemical & Energy industries.

Investment Arguments

Experienced promoters with a long track record of operations The company is managed by Sachin Agarwal, Managing Director, who has an extensive experience of more than three decades in the industry. This has helped the company establish itself across geographies while maintaining strong associations with reputed government and private customers, withstanding changes in industry cycles and diversifying the products profile, which has been reflected in the consistent income and healthy profitability over the years.

Diversified product portfolio with specialised metal castings The company is engaged in the manufacturing of a wide range of specialised products largely used in defence machinery components, such as alloy and non-alloy steel castings, titanium castings, machined components, and fabricated parts. The specialised nature of the products and the diversified portfolio safeguard the company from the cyclicality of the industry to an extent and also reduces the risk of a slowdown in any particular segment.

Widespread geographical presence with a reputed customer base The company has a diversified industrial client base, which reduces the risk associated with any particular client or end-user segment, as it caters to different industries including aerospace, oil and gas, marine, energy, etc. During FY24, Finland, the US, and China were the largest contributing countries with more than 50% revenue generation. The geographical diversification protects the company from the adverse impact of a slowdown in a particular country. With the advent of titanium casting technology in India, PTC is focussing on many critical defence and aerospace parts while also increasing avenues for the export of these components from India.

PTC Industries—Emerging as India's leading titanium and other super alloy manufacturer PTC Industries Ltd. (established in 1963 and currently headquartered in Lucknow, Uttar Pradesh) is among the leading global suppliers of high-precision metal components for super-critical operations across a wide range of segments including aerospace, defence, and industrials. The company has developed competency in manufacturing platform-independent castings which find end usage across civil aviation, air defence, naval defence, space, and aero engines. The company's current business interests and verticals can be clubbed together into three groups—(1) Industrials & Defence Group, (2) Aerospace Castings Group, and (3) Aerospace Materials Group. The existing business can be clubbed as the Industrials & Defence Group while the ongoing expansion at the 15,000 square meter facility at the new 50-acre land in Lucknow in the UP Defence Industrial Corridor would comprise of the second and third grouping.

PTC Industries Ltd

Q4FY24 Financial Performance PTC Industries delivered remarkable financial performance for the quarter ended Q4FY24. Consolidated net sales rose 16% YoY to Rs.72 cr as compared to Rs.62 cr registered in the same quarter of corresponding fiscal. On the operational front, consolidated EBITDA witnessed a growth of 37% YoY to Rs.26 cr.  EBITDA Margin expanded by 370 bps at 33.9% YoY. PAT surged by 60% YoY to Rs.15 cr aided by healthy topline growth and strong operational performance.

Anant Raj Ltd

Construction - Real Estate


Stock Info
  • BSE 539302
  • NSE ANANTRAJ
  • Face Value (Rs) 2
  • Equity Capital (Rs cr) 68
  • Mkt Cap (Rs cr) 12,282.43
  • 52w H/L (Rs) 375.00 - 137.35
Shareholding pattern
  • (as on 31-Mar) %
  • Promoter 60.01
  • FIIs 11.52
  • DII 3.63
  • Public & Others 24.83
Published Date May 09, 2024
Current Market Price Rs. 372.00
Rating Buy

ANANTRAJ Buy

Anant Raj Ltd

Rs. 372.00

May 09, 2024

BSE 539302
52W high 375.00
52W low 137.35
Face Value Rs.2
Return (%) 1m 3m 12m
Absolute 6.29 4.59 150.35
Sensex -1.71 2.85 18.95
Anant Raj Ltd Sensex

Key beneficiary of the upswing in real estate market

Company Profile

PEstablished in 1969, Anant Raj Ltd (ARPC) is a prominent EPC player in Delhi-NCR for the first 30 years of its operations, where it executed construction and civil contracts for the Government. Currently, the company owns more than 300 acres of land parcels, of which more than 75% is concentrated in Sector 63A, Gurgaon. The balance is spread across multiple locations in Delhi and Haryana. Till date, ARCP has delivered more than 20mn sq. ft. of residential projects, utilizing ~60 acres of the land bank. Over the remaining land parcels, it has ongoing developments of ~2.4mn sq. ft. and plans to add another ~5.5mn sq. ft. in the near term. The projects are a balanced mix of group housing, plots, independent floors and commercial buildings, catering to premium and above categories. The company also has a comprehensive annuity portfolio where it owns and operates office and hospitality assets and is foraying into high growth data centre segment with plans to develop a load handling capacity of 300MW over 7-8 years. It has a comprehensive portfolio of residential townships, group housing projects, commercial developments, data centres, and hospitality developments spread across Delhi, Gurugram, and NCR.

Investment Arguments

Cyclical upswing in Gurugram’s residential real estate market Gurugram is the largest residential real estate market in Delhi-NCR, contributing ~52% of total area absorbed. The upswing in the sector began in FY19/20 and post COVID, the market saw a significant surge in demand on i) increased preference for ownership, ii) requirement of a larger space suiting work-from-home lifestyle, iii) deployment of household savings in real estate and iv) correction in prices. In FY23, Gurugram was the best performing market, with absorption growing 95% YoY (pan India absorption growth of 30.3%). Supply grew 188% YoY on a low base, but lagged absorption, leading to inventory declining to an all-time low of ~7 months in Mar 2023. We expect the demand momentum to continue on i) strong consumer sentiment, ii) increasing preference for branded inventory, and iii) a continuing shift of commercial centres from Delhi to Gurugram. Record low inventory levels and constrained supply is expected to drive price appreciation. With more than 170 acres of land bank located in Sector 63A of Gurugram, Anant Raj Ltd is expected to be one of the key beneficiaries of the robust demand.

Scaling up launches to capitalize on the resurgent demand Anant Raj Ltd has planned multiple launches across product categories such as plotted development, group housing, villas and independent floors over ~140 acres of licensed developable land in Sector 63A, Gurugram. As of September 2023, it was ~2.26mn sq. ft. under development with unsold inventory of 0.65mn sq. ft. (GDV - ~INR818cr). It has planned to launch another 5.46mn sq. ft. over FY24 and FY25 with a GDV of INR 7974cr. Post these developments, ARCP will still be left with ~30 acres of land. Apart from Sector 63A, it has land parcels of ~83 acres spread across Delhi and Haryana, for which it is yet to finalize development plans.

Steadily growing Annuity Portfolio ARCP’s commercial properties are spread across NCR and cater to the office, retail, and hospitality segment. It operates three IT parks with a leasable area of 4.65mn sq. ft., two hospitality assets spread over 0.2mn sq. ft., and one retail asset spread over 0.1mn sq. ft. The hospitality assets have been leased at a fixed rate. It is in the process of adding another office asset (Ashok Tower) in Gurugram with a leasable area of 0.16mn sq. ft. and an estimated monthly rental value of INR90 per sq. ft. As per the management, this office asset is expected to launch in FY24 and turn operational by June 2025. ARCP expects steady-state annual rentals of INR17–18cr once it is fully occupied.

Well positioned to capitalize on the growing demand for data centres To capitalize on the growing demand for data centers in and around Delhi-NCR, ARCP forayed into the building and leasing of such centres in FY24. It has aggressive plans to expand this business by retrofitting and remodelling its commercial office assets at three locations into best-in-class data centres. It plans to develop a combination of Tier III and IV data centres with a 300MW IT load capacity.

Manesar (Haryana) — 3MW leased out to TCIL and RAILTEL each Anant Raj Tech Park is one of the firm’s first assets in the data storage domain, located 10km from Gurugram, which is the IT and BPO hub in NCR. It is spread over 10 acres, with a leasable area of 1.8mn sq. ft. The existing structure can be converted into a Tier III data centre, with an IT load capacity of 50MW. In the first phase, ARCP plans to build a 21MW IT load capacity data centre over 450,000sq. ft., of which 3MW has been completed. It has received TIA-942 Tier III certification for the first phase. The management pegs the average monthly rental potential ~INR9,000/kW and the average cost of constructing ~INR26cr/MW. In the second phase, it plans to expand its IT load capacity to 50MW.

Anant Raj Tech Centre, Rai (Haryana) — 200MW potential The Anant Raj Tech Centre is spread over 25 acres in Rai, with a development potential of 5.1m sq. ft. It is just 5km from NCR and is connected to the airports at Gurugram and Manesar by the Kundli–Manesar–Palwal Expressway. Going forward, the area is expected to be connected to the Delhi Metro. ARCP has a leasable area of 2.1mn sq. ft., which it plans to convert into a Tier III data centre with a 100MW IT load capacity. It plans to add 1.5mn sq. ft. of leasable area, which can host 100MW of Tier III and IV data centres. This will be its largest data centre.

Anant Raj Tech Park, Panchkula (Chandigarh) — 50MW potential The Anant Raj Tech Park at Panchkula is a JV between ARCP and US-based Monsoon Capital. It is spread over 9.2 acres and has a development potential of 1.6mn sq. ft. Till date, it has developed 0.6mn sq. ft., which it has leased out to commercial offices. The asset has a greenfield potential of 5.25 acres, with an FSI of 0.6mn sq. ft., that can be developed into a Tier IV data centre with an IT load capacity of 50MW.

Q4FY24 Financial Performance Anant Raj displayed remarkable earnings growth for the quarter ended Q4FY24. Consolidated net sales rose 58% YoY to Rs.443 cr as compared to Rs.280 cr in the same quarter of corresponding fiscal. On the operating front, consolidated EBITDA witnessed a robust growth of 41% YoY to Rs.104 cr. EBITDA Margin stood at 24% YoY. PAT surged to Rs.84 cr, an increase of 75% YoY aided by healthy topline growth and impressive operational performance. The company achieved a record-breaking year in FY24 with a topline exceeding Rs.1500 cr and a PAT of Rs.265 cr. 

Other Key Developments

  • Successful Real Estate Projects: Three real estate projects (group housing, villas, and independent floors) launched in the previous year were well-received and achieved higher-than-expected pricing.
  • Data Center Expansion: Anant Raj has become a major player in North India's data center industry with 3 megawatts operational and an additional 3 megawatts nearing completion. The company has also signed an agreement with TCIL to provide cloud services, introducing a new revenue stream with significant growth potential.
  • Future Real Estate Plans: The company is prepared to launch new group housing projects and independent floor projects in FY25, totaling 1.45 million sq ft, with ample land bank remaining for future development.
  • Data Center Growth: The Company plans to have 28 megawatts operational by December 2024, with a long-term goal of reaching 300 megawatts within the next four years.

Jupiter Wagons Ltd

Auto Ancillary


Stock Info
  • BSE 533272
  • NSE JWL
  • Face Value (Rs) 10
  • Equity Capital (Rs cr) 399
  • Mkt Cap (Rs cr) 15,941.33
  • 52w H/L (Rs) 434.00 - 93.45
Shareholding pattern
  • (as on 31-Dec) %
  • Promoter 70.12
  • FIIs 1.26
  • DII 2.05
  • Public & Others 26.55
Published Date April 03, 2024
Current Market Price Rs. 387.30
Rating Buy

JWL Buy

Jupiter Wagons Ltd

Rs. 387.30

Apr 03, 2024

BSE 533272
52W high 434.00
52W low 93.45
Face Value Rs.10
Return (%) 1m 3m 12m
Absolute 5.37 21.46 299.38
Sensex 0.13 2.80 25.04
SOM DIST & BREW Ltd Sensex

Ramp up in capacity and healthy order book to drive growth for JWL

Company Profile

Jupiter Wagon Ltd (JWL), incorporated in 2006, a part of the Kolkata-based Jupiter Group and a leading player in the Indian railway wagon manufacturing industry. JWL is currently engaged in manufacturing railway wagons, wagon components, weldable CMS crossings, load bodies for commercial vehicles and containers. JWL has its manufacturing units located at Kolkata (West Bengal), Jabalpur (Madhya Pradesh), Jamshedpur (Jharkhand), Indore (Madhya Pradesh) and Baddi (Himachal Pradesh). It has capacity to manufacture ~9,600 wagons annually and is backward integrated with a foundry shop to manufacture various components of a typical wagon like couplers, bogies, draft gears, CRF section, etc.

Investment Arguments

Established market position supported by technology tie-ups and partnerships JWL is one of India’s largest wagon manufacturers, with a capacity of 9,600 wagons per annum with plans to enhance capacity to 12,000 wagons per annum by Q1 fiscal 2025. Over the years, it has gained significant experience and has established strong relationships with government and private customers in iron & steel, power, logistics, mining, cement sectors and other reputed OEMs resulting in steady order inflow. Technology tie ups and partnerships with global entities have strengthened JWLs technical know-how and capabilities. This has resulted in a wide product portfolio and diversification from core wagon manufacturing business. In fiscal 2023, JWL derived ~ 80% revenue from wagon segment, ~15% from commercial vehicle (CV) load bodies and remaining ~5% from sale of containers and other track items. Furthermore, JWL has also ventured in brake disc, brake systems for rolling stock and weldable CMS Crossing manufacturing during fiscals 2023-24 equipping JWL to capitalize on robust spendings for developing high speed train infrastructure, and to fortify its market position in this segment, in Q1 fiscal 2024 JWL has acquired Stone India Limited, having extensive infrastructure and licensing for brake manufacturing. Benefits of robust spendings, onboard of technology partners, healthy order inflow and investments in capacity expansion and strategic backward integration is expected to drive growth in JWLs scale of operations over the medium term.

Triumph in order securing amid government’s focus on the sector to bode well for JWL Order backlog currently stands at Rs.7,070 cr (vs Rs.5,950 cr Q2FY24), secured severalsignificant contracts both from IR and pvt companies during Q3FY24. Order of 4,000BOXNS wagons from IR (~Rs1,620 cr order value) was the highest, followed by a defenceministry order worth Rs.470 cr for Boggie Open Military wagons. These orders furthersolidify JWL’s position in the wagon manufacturing business. In its interim budget thegovernment has allocated ~Rs11.11tn (11% YoY) for capex outlay and plans to establishthree significant corridors aimed at addressing congestion issues to facilitate fasterfreight movement, reduce turnaround time, and lower logistic costs shall improve JWL’sfreight wagon business, 40,000 bogies conversion into Vande Bharat bogies is expectedto provide a boom in JWL’s component making business.

Growth levers remain robust while industry tailwinds continue to support There are various growth triggers for the company which include, 1) order backlog of Rs.7,070 cr providing robust revenue visibility 2) capacity of 9,600 wagons per annum with plans to enhance capacity to 12,000 wagons per annum by Q1 fiscal 2025 3) Higher execution of private orders expanding margins which is up 140bps YoY to 13.9% in Q3FY24 4) Commissioning of braking system at Stone India to fulfil itscaptive requirement 5) contributionfrom Kovis and Dako JV to plant to contribute 5-6% by FY25 at the bottom line whichcaters to a TAM of Rs50 bn 6) Electric Mobility: the vehicle is scheduled for comprehensive testing inNovember and are progressing as planned for its commercial launch in Q4FY24.

Opportunity in replacement demand Currently India is a net importer of wheels, sourcing close to 100,000 wheelsets from China to meet its requirement in passenger and metro coaches and freight wagons. The company is seeing this as a big opportunity for domestic manufacturing. Also, with Tatravagonka as a strategic investor in Jupiter Wagons (with a 19.24 per cent stake), they are keen on export opportunities in Europe. Overall, the company expect a business of around Rs 1,000 crore from forged wheels in the next 3-5 years.

The company has forged partnerships and made acquisitions to expand the components business.The company has recently announced the acquisition of Bonatrans India Private Limited for Rs 271 crore which already has a plant in Aurangabad, with a production capacity of 20,000 wheels and 10,000 axles, annually.Including Stone India, in the next 3-4 years company want the braking business to be about Rs 1,000 crore. JWL aim to have 80% of whole value chain inhouse.

Strong and long – lasting relationship with customers Jupiter Wagons has established long-standing relationships with many of its customers. They are a trusted partner and strategic supplier to, and have longstanding, extensive relationships with, leading Indian OEMs in commercial vehicles space, wagon leasing companies, auto car manufacturer, freight aggregators, shipping and container logistics companies etc. Being a diversified product manufacturer, we believe that strategically located manufacturing facilities, consistent performance, and adherence to quality standards has helped them maintain customer engagements and attract almost all the key manufacturing brands.

Strategic alliances with global partners JWL has partnerships with leading global companies via Joint Ventures (JVs) for manufacturing brake disc, brake systems for rolling stock and weldable CMS Crossings through JWL DakoCz India Limited, JWL Kovis (India) Private Limited &JWL Talegria (India) Private Limited. It has recently entered the electric mobility sector through subsidiary, Jupiter Electric Mobility Private Limited, concentrating on e-LCV for last mile delivery. Its subsidiary, Habitation Real estate LLP, has no business operations.

Jupiter

Q3FY24 Financial Performance Jupiter Wagons Ltd delivered healthy earnings growth for the quarter ended Q3FY24. Standalone net sales rose 39% YoY to Rs.896 cr as compared to Rs.644 cr clocked in the same quarter of corresponding fiscal due to asharp jump in manufacturing performance across business segments, despite the 10-day production loss on account of festive seasons during Q3FY24. Gross margins scaledup by 21bps/129bps YoY/QoQ to a healthy 23.1% owing to higher execution of privatewagons which led to an EBITDA growth of 55% YoY to Rs.125 cr. EBITDA Margin expanded by 140 bps at 13.9%. PAT registered a solid growth of 80% YoY to Rs.83 cr aided by healthy topline growth and steady operational performance. PAT Margin stood at 9.3%.

Key conference call takeaways

  • Margin Improvement: The addition of Jabalpur unit is expected to result in significant cost savings, especially in freight expenses. The strategic focus on improving backward integration, reducing freight costs and implementing production efficiency measures are designed to further enhance operational efficiencies, laying the ground for an enriched margin profile.
  • Capacity Expansion: The company expects Rs.700 cr of incremental capex by end ofnext financial year largely towards new foundry at Jabalpur, Wheel setmanufacturing capacity and expansion of existing foundry at Kolkata. Expectcapacity to grow to 800 wagons/month by end of FY24 and ~1000wagons/month at the end of FY25.
  • Electric Mobility: Awaiting ARAI certification, the vehicle is scheduled for acommercial launch event in Q4FY24.
  • InterimBudget: For Energy, mineral and cement sectors the government is keento build railway corridor, to ease Port connectivity and High traffic densityespecially in eastern part of the country. Under PM Gati shakti, the efforts willimprove logistics efficiency and reduce cost while it will improve passenger trainsafety and comfort. Three economic corridor programs to accelerate GDPgrowth and reduce cost. 40,000 normal rail bogies will be converted to Vandebharat bogies, JWL is one of the component supplier for Vande Bharat.
  • Order book split: Total order backlog of Rs.7070 cr (60% private and 40% IRorders). The wagon business won orders of over Rs.2200 cr in Q3FY24 from the IRand private customers (Substantial Rs.1620 cr order from IR (4,000 BOXNS), aRs.470 cr order from the Defence Ministry (697 Boggie Open Military wagons) anda Rs.100 cr order from one automobile manufacturer for 4 sets of double deckerautomotive carrier wagons.

Pitti Engineering Ltd

Engineering


Stock Info
  • BSE 513519
  • NSE PITTIENG
  • Face Value (Rs) 5
  • Equity Capital (Rs cr) 16
  • Mkt Cap (Rs cr) 2,377.95
  • 52w H/L (Rs) 757.80 - 255.60
Shareholding pattern
  • (as on 31-Dec) %
  • Promoter 59.29
  • FIIs 0.22
  • DII 6.56
  • Public & Others 33.94
Published Date February 27, 2024
Current Market Price Rs. 762.00
Rating Buy

PITTIENG Buy

Pitti Engineering Ltd

Rs. 762.00

Feb 27, 2024

BSE 513519
52W high 757.80
52W low 255.60
Face Value Rs.5
Return (%) 1m 3m 12m
Absolute 14.33 10.49 154.01
Sensex 1.18 10.00 22.77
Pitti Engineering Ltd Sensex

Value added products and long standing relationship with marquee customers to drive growth

Company Profile

Incorporated in September 1983, Pitti Engineering Ltd (PEL) was promoted by Mr Sharad B Pitti of Hyderabad, Telangana. PEL manufactures value-added and assembled components through machining and lamination processes for several end-user industries in India and international markets. It has the distinction of being the first lamination manufacturer in India and the first company in the state of Andhra Pradesh to be certified as an ISO 9002 company. The company has state-of-the-art manufacturing facilities, located at Hyderabad (Telangana) and Aurangabad (Maharashtra) with a capacity of 15,000 and 35,200 MTPA respectively as of FY23). It manufactures electrical steel laminations, sub-assemblies for motor cores, sub-assemblies for generators, die-cast rotors, and machining of metal components. The end users of the products of PEL include Power, Mining, Transportation, and Heavy Industrial Motors segments.

PEL is one of the largest manufacturers and exporters of electrical laminations in India and one of the market leaders of assemblies for large alternators and motors in India.

Investment Arguments

New business opportunities– key growth drivers for the company The company has successfully expanded its presence and capabilities to service new value-added businesses. The company has added dedicated manufacturing lines/units for new applications segments which include railway undercarriages, components for EV (Electric Vehicle) motors, drivetrain systems, gear cases, unique engineered product solutions for wind turbine applications, and medium and heavy fabricated machined components. The company has a diversified product portfolio that caters to diverse end-user industries including Power, Mining, Transportation, Hydro generator, Electric Vehicle Motors, etc. PEL exports its products to more than 12 countries deriving a revenue of around 40% of total revenue as of Q3FY24.

New business opportunities

Long–standing relationship with a marquee customer base PEL is an established player for stamping and lamination segments in both domestic as well as overseas market and its clientele comprises renowned names in the industrial motor manufacturing industry such as Wabtec Corporation (WC), General Electric (GE), Siemens Limited, ABB India Limited, Larsen & Toubro, Suzlon Energy, Mitsubishi Electric, Wabtec Corp, Titagarh among others from whom the company garners repeated orders. A strong relationship with the marquee customer base should enable the company to garner repeat orders.

long standing

Capacity expansion to cater to strong industry tailwinds PEL’s investment in capacity expansion will help in increasing its offerings and reach customers quickly. It has proposed capacity expansion of sheet metal to 72,000 tonnes (current 50,200 tonnes) and machining to 648,000 hours (current 460,800 hours) – which is to be operational by Q1FY25, and which will further strengthen its revenue earning potential. In addition, debottlenecking and automation exercises at Hyderabad will add to profitability levels. It has already set up its facility at Aurangabad, Maharashtra, and since Maharashtra accounts for ~60% of its domestic business, this move will help PEL to reach customers faster, easily source raw materials, and significantly reduce its logistics and operational costs.

The company’s Maharashtra facility is under the Mega-Project Incentive Packaging Scheme 2013, PEL will receive incentives from the state government by way of SGST reimbursement (on sales made from the Aurangabad plant) based on the capex – if PEL’s capex is ~`700mn, then its incentive will be `100mn p.a. by way of SGST reimbursement spread over seven years. This will also boost profitability. Capacity at the plant in Aurangabad can be easily extended to 100,000 MT without any requirement for additional land.

Capex-driven economy to support robust order book In FY23, PITTI’s order book significantly improved by 149% YoY to Rs 823 Cr backed by a) a diversified product basket, and b) robust demand from the domestic market on account of economic growth and increasing enquiries from the international market. We expect the company’s order book to further improve given the increasing growth and demand from the Railways, Power Generation, and Industrial sectors for the company’s products. To cater to this demand, PEL has already carried a major Capex of Rs 467 Cr in a phased manner from FY21. This has increased PEL’s production capacity by ~56% in the last 3 years. Earlier, PEL used to supply products to 100 windmills a year whereas, with increasing demand in the renewable energy segment, PEL is currently supplying its products to 100 windmills per month. This supply is expected to further increase as many players have made India a hub for sourcing for its South Asian country's needs. Capex is pegged at Rs.223 cr by H1FY25.

Value-added products yield higher realizations PEL has strategically evolved its products to meet market demands, resulting in the company's profitability improvement. These value-added products have also helped the company to enhance its competitive edge and attract more customers. These value-added products have also helped the company to enhance its competitive edge and attract more customers. The company achieved the highest ever Export Revenue per quarter ₹ 118.29 Crores. Similarly, with increasing demand in the renewable energy segment in the international market, we believe the export market will significantly aid in PEL’s revenue growth and improve its profitability moving forward.

Pitti Casting (PCPL) Merger and potential acquisition PEL recently announced the merger of Pitti Castings Pvt. Ltd. – a group company engaged in the manufacturing of high-quality casting in grey iron, ductile iron, low carbon, and alloy steel grades. Post-merger, PCL’s revenue is expected to grow significantly on account of robust demand in the components business, leading to higher operating margins for the company. In FY23, PCPlL’s revenue stood at Rs 150 Cr, in which PEL contributed Rs 80 Cr. This merger will aid the company in ensuring a consistent supply of high-quality casting products and will have enhanced control over the supply and inventory management of raw materials. PEL is also looking into potential acquisitions to further increase its market share and sales volume by 20%.

Key Growth drivers for the company

Significant investment by railways will drive PEL’s growth The Indian Railways’ capex outlay for FY24 stands at a substantial ` 2.4tn, which is more than 9x its 2014 capex. Railways will be net-zero by 2030 and will introduce more semi-high-speed [Vande Bharat trains by 2030. The aim is to roll out more than 800 operational Vande Bharat trains by 2030. Siemens (to whom PEL supplies) recently bagged a ` 250bn project from the railways, manufacturing 1,200 electric locomotives with a horsepower of 9,000. All these initiatives will boost PEL’s revenues.

EV is the new revenue driver for PEL EV sales in FY23 increased by ~174% YoY to 1.25mn units. The Indian government has set a target to achieve 30% electrification of the country's vehicle fleet by 2030 and has introduced several incentives and policies to support the growth of the EV industry. The industry was given a major boost in the FY24 Union Budget to produce electric vehicles, adoption of hydrogen fuel, and embracing changing technologies, etc., with a budget of ~ ` 350bn.

China+1 is a big opportunity for fabrication services The convergence of supply-chain constraints and the strategic adoption of the ‘China Plus One’ approach offers the potential for PEL to capitalize on the growing demand for fabrication services, establishing a strong market presence and driving sustainable growth in this dynamic industry. Recognizing the potential of this business, PEL made a strategic investment of ` 70mn to establish a dedicated production line equipped with state-of-the-art technologies such as fibre laser cutting for sheet metal, automated CNC bending machines, robotic welding solutions, specialized heat treatment, and painting lines.

Government’s plans for 500GW renewable energy by 2030 The government has outlined plans to increase renewable capacity from 166GW at present to 500GW by 2030; for this, the transmission capacity needs to be augmented (higher gestation period vs. generation). Accordingly, investments have been planned out in phases over FY23-30 at an estimated cost of ~ `2.44tn.

The Pump Market is another strong business opportunity for PEL The global pump market is valued at US$ 96bn in 2022 and is estimated to touch US$ 119.39bn by 2028, at 6.3% CAGR. Exports have been growing at 10-12% annually, with India exporting pumps and valves to 100+ countries, serving different segments. The exports of all types of pumps from India were valued at US$ 98.7mn in 2022, rising 25% to US$ 123.5mn in 2023.

Global traction motors are poised for strong demand Governments worldwide are actively promoting the adoption of electric vehicles and electrification of transportation systems to reduce carbon emissions and combat climate change. Such incentives are encouraging manufacturers and consumers alike to embrace electric propulsion technologies, thus fueling the demand for traction motors. Also, as countries strive to modernize and expand their railway networks, the demand for traction motors for locomotives, high-speed trains, and other rail transport vehicles is witnessing a notable upswing. Industries such as automotive, transportation, and industrial equipment are increasingly seeking efficient and powerful traction motors to enhance their products' performance and energy efficiency. Favorable government policies and subsidies have played a crucial role in bolstering this industry.

Q3FY24 Financial Performance Pitti Engineering delivered robust earnings growth for the quarter ended Q3FY24. The company achieved the highest-ever sales volume of 10,572 MT in Q3FY24, with YoY growth of sales volume is 15.54% as against 9,150 MT in Q3FY23. Total revenue for Q3FY24 is ₹ 296.92 Crore as against ₹ 239.08 Crore in Q3FY23, registered a growth of 24.19% on year-on- year basis and achieved the highest ever Export Revenue per quarter ₹ 118.29 Crore. EBIDTA for Q3FY24 grew by 13.58% year-on-year growth to ₹ 44.09 crore, the highest ever EBITDA registered for the quarter. The Company has achieved net profit of ₹ 13.32 crore in Q3FY24, achieving a year-on-year growth of 9.81%.

Kalyan Jewellers India Ltd

Diamond & Jewellery


Stock Info
  • BSE 543654
  • NSE KALYANKJIL
  • Face Value (Rs) 10
  • Equity Capital (Rs cr) 1,030
  • Mkt Cap (Rs cr) 45,166.63
  • 52w H/L (Rs) 464.95 - 127.15
Shareholding pattern
  • (as on 31-Mar) %
  • Promoter 60.63
  • FIIs 21.10
  • DII 11.00
  • Public & Others 7.26
Published Date June 26, 2024
Current Market Price Rs. 449.75
Rating Buy

KALYANKJIL Buy

Kalyan Jewellers Ind Ltd

Rs. 449.75

Jun 26, 2024

BSE 543654
52W high 464.95
52W low 127.15
Face Value Rs.10
Return (%) 1m 3m 12m
Absolute 7.85 9.29 236.73
Sensex 3.53 7.70 23.95
Kalyan Jewellers India Ltd Sensex

Store expansion and wide product offerings to drive growth

Company Profile

Kalyan Jewellers India Ltd. (KJIL), founded in 1993 by Chairman and MD Mr. T.S. Kalyanaraman, designs, manufactures, and sells a variety of gold, studded, and other jewellery products across various price points. As one of India's largest jewellery retailers, Kalyan Jewellers has a well-established market presence spanning over three decades. Its product range includes items suitable for special occasions, such as weddings, as well as pieces ideal for everyday wear. Their wide product offerings make KALYAN a one-stop destination for all their jewellery needs. The company has expanded to become a pan-India jewellery player, with 217 showrooms located across 23 states and a union territory in India. Additionally, it has an international presence with 36 showrooms located in the Middle East as of March 24.

Kalyan Jewellers
Investment Arguments

Strong demand despite higher gold prices Despite higher gold prices, demand for jewelry remained strong, and the company experienced robust volume growth during the mini wedding and festive season, particularly driven by Akshaya Tritiya. Kalyan's average store size ranges between 3,000-4,000 sq. ft., with an average inventory of approximately Rs 20-25 crores. The company is focusing on expanding its presence in Tier 2 and Tier 3 markets by opening more Franchise-Owned, Company-Operated (FOCO) stores. Kalyan believes its hyper-local model is well-suited for semi-urban and rural regions, as it caters to local preferences for gold and studded jewelry. Mature stores are achieving low double-digit Same Store Sales Growth (SSSG), and the contribution from new buyers remains robust at over 40%. With a higher share of studded jewelry, the ticket size is better than in South markets. The competitive environment, coupled with rising gold prices, has led to attractive consumer offers, such as 50% off on making charges, driving footfalls. Looking ahead, the company expects the festive season to further increase footfalls.

Favourable industry growth prospects Increasing regulatory restrictions in the jewelry sector, aimed at enhancing transparency and compliance, are leading to a shift in market share towards organized jewelry retailers. This trend is expected to benefit KJIL (Kalyan Jewellers India Limited) due to its widespread presence across India and strong brand equity. KJIL will continue to expand its revenue base, leveraging industry tailwinds in the medium term. This growth is supported by a loyal customer base and an extensive network of 'My Kalyan' stores.

Established Brand Image; Diversification across Geography and Products Kalyan is among India’s top five gold jewellery retailers, accounting for about 6% of the total organised market share as per the company. As of March 31st, 2024, KALYAN operated a total of 217 showrooms in India, which includes 13 Candere showrooms, spanning across 23 states and a union territory. These showrooms collectively cover an area of 700,000 square feet. Additionally, KALYAN has 36 showrooms in the Middle East, covering a total area of 44,000 square feet.

Approximately 86% of KALYAN's showrooms, including Candere, are located in India, while the remaining 14% are situated in the Middle East. Regionally, KALYAN has a presence in 38% of its stores in the South and 62% in non-southern regions. Furthermore, 30% of the showrooms are located in metropolitan areas, with the remaining 70% situated in non-metro areas.

Nationwide expansion into non-southern regions to boost margins KALYAN, originally based in Kerala, has expanded its operations to 23 states and a union territory in India. The favourable industry dynamics for organized players are expected to continue driving store-led growth for nationwide brands like KALYAN and Tanishq. KALYAN's success in non-southern markets has encouraged it to accelerate its store expansion plans. The company aims to leverage the strong demand for studded jewellery in these regions.

In India, studded jewellery accounts for 22% of sales in southern markets and 35% in non-southern markets. Studded jewellery typically carries a higher gross margin of around 35% in India, with margins in non-southern markets exceeding those in the south, compared to plain gold jewelry, which typically has margins of 11-12%. Hyper-local strategies for different geographies and customer segments

Hyper-local strategies for different geographies and customer segments KALYAN's hyper-local strategy allows it to provide tailored services across diverse regions and customer segments in India, where jewellery preferences vary widely. This approach requires a deep understanding of local preferences and the use of region-specific inventory models. The company employs region-specific campaigns featuring localized content and brand ambassadors who appeal to national, regional, and local audiences. Each showroom is staffed with local personnel who understand the local language and culture, and the showroom designs reflect local tastes. Moreover, KALYAN's "My Kalyan" network hires employees from local communities to ensure they have relevant language skills and local relationships. This strategy enhances the brand's connection with customers and strengthens its presence in various regions across India.

Focusing on the asset-light FOCO model KALYAN has developed a strategy to operate using both the Company Owned, Company Operated (COCO) and Franchise Owned, Company Operated (FOCO) models in both Indian and international markets. This approach is aimed at adopting an asset-light strategy to reduce leverage on its balance sheet. In the upcoming fiscal year, FY25, the company plans to open 80 new FOCO stores in India and six stores internationally. Additionally, it intends to shift its focus more towards the FOCO model compared to the COCO model in the Middle East. Over the long term, KALYAN aims to convert 20 stores from COCO to FOCO. To facilitate this transition, KALYAN has partnered with a global investment bank. This strategic move is expected to strengthen the company's presence in key markets and improve its financial performance by reducing asset ownership and associated costs.

Q4FY24 Financial Performance KJIL demonstrated robust financial performance with impressive year-on-year growth. Overall, revenue surged to Rs 4,535 crores from Rs 3,382 crores, marking a stellar 34% increase, driven by strong footfalls ahead of the wedding season. EBITDA surged 19% to Rs 306 crores, from Rs 256 crores in Q4FY23, despite 80bps decline in EBITDA margin due to higher operating expenses. Notably, PAT soared to Rs 137 crores from Rs 70 crores, marking a growth of 97%.

Its India business recorded a 38% YoY growth in Q4FY24, up from Rs 2805 crores to Rs 3876 crores in Q4FY24 on the back of healthy same-store sales growth, the highest in all FY24 quarters. PAT was standing at Rs 131 crores from Rs 66 crores in previous year's quarter which is an upside of 99%.

In Q4 FY24, revenue from operations in the Middle East amounted to Rs 624 crore, marking a 14% increase from Rs 549 crore in the previous fiscal year's Q4. The quarter's PAT reached Rs 9.9 crore, up by 76% from Rs 5.6 crore in the corresponding quarter of the previous year.

In Q4 FY24, Kalyan's digital platform, Candere, generated revenue of Rs 36 crore, compared to Rs 32 crore in the same quarter of the previous year. The quarter reported a loss of Rs 70 lakh, a decrease from the loss of Rs 1.9 crore in the corresponding quarter of the previous year.

India Performance:

  • India business recorded a 38% YoY growth in Q4FY24, to Rs.3876 crores in Q4FY24 on the back of healthy same-store sales growth, the highest in all FY24 quarters. PAT nearly doubled to Rs.131 crores from Rs 66 crores in previous year's quarter.
  • Strong revenue growth in South driven by 18% SSSG.
  • Non-South region also showed robust growth at 16% SSSG.
  • Non-South region's revenue share increased to 49% from 44% YoY.
  • Studded jewellery outperformed gold, with a growth of 29% and increased share to 29% from 28% YoY.

Middle East Performance:

  • Positive consumer sentiment in the region.
  • Stable showroom-level gross margins YoY.
  • Revenue from FOCO showrooms impacted overall gross and EBITDA margins as expected.
  • Two new showrooms successfully launched in Q4FY24.
  • Higher finance costs due to rising interest rates in the region.
Key Conference call takeaways

Capex and Debt Reduction Strategy:

  • Aim to reduce debt by around INR 400 crores next year.
  • Estimated capex for the next year is around INR 250 crores.
  • Plan to cut working capital loans by INR 350-400 crores by March 2025.
  • Starting discussions with banks to release real estate collaterals linked to the working capital loans reduced during FY24.

Franchise Model:

  • Expected franchise revenue share is around 20%.
  • New franchise stores projected to achieve a PBT margin of 5%.
  • Other income includes rent from franchise partners.
  • Premises leased and subleased to franchise owners.

Future Plans:

  • Plan to open 130 showrooms in India: 80 under the Kalyan brand and 50 under Candere.
  • Aim to launch 6 overseas showrooms during the current financial year.
  • Free cash flow to be used to further reduce working capital loans.
  • Focus on cutting non-GML loans and securing additional GML limits.
  • With a focus on growth and customer-centric strategies, Candere is poised to achieve exponential market expansion and strengthen its position as a leading player in the industry.

Market Insights:

  • Strong SSSG observed in both South and non-South regions.
  • Encouraging consumer demand momentum, especially for wedding purchases.
  • Stable competition intensity with no major impact on pricing over the past 4-5 quarters.
  • Increased advertising spend, impacting margins due to heightened ad campaigns by competitors.
  • Franchise revenue share expected to rise, affecting overall margins.

Financial Outlook:

  • PBT margins expected to improve due to debt reduction and leverage benefits.
  • Interest costs to decrease, as debt is reduced, enhancing profitability.
  • Depreciation likely to remain stable with a focus on reducing capex.
  • Revenue growth and cost management are key factors for achieving higher profitability in the future.

FY25 Expansion: Launching 80 FOCO Kalyan showrooms across India.

Middle East Expansion: First FOCO showroom launched in FY24, with 5 more Letters of Intent (LOIs) signed for FY25.

Candere Showrooms: First FOCO Candere showroom opened in FY24, totaling 8 FOCO showrooms by March 31, 2024, and a robust pipeline with 50 signed LOIs for FY25.

Conversions: Two owned showrooms in South India converted to FOCO in FY24, with additional conversions planned for FY25.

Lupin Ltd

Pharmaceuticals & Drugs - Global


Stock Info
  • BSE 500257
  • NSE LUPIN
  • Face Value (Rs) 2
  • Equity Capital (Rs cr) 91
  • Mkt Cap (Rs cr) 64,021.19
  • 52w H/L (Rs) 1412.90 - 628.00
Shareholding pattern
  • (as on 30-Sep) %
  • Promoter 47.06
  • FIIs 14.99
  • DII 29.14
  • Public & Others 8.80
Published Date January 04, 2024
Current Market Price Rs. 1408.00
Rating Buy

LUPIN Buy

Lupin Ltd

Rs. 1408.00

Jan 04, 2024

BSE 500257
52W high 1412.90
52W low 628.00
Face Value Rs.2
Return (%) 1m 3m 12m
Absolute 11.58 19.82 90.64
Sensex 3.62 8.92 16.42
Lupin Ltd Sensex

Improved product mix and new product launches to spur growth for Lupin

Company Profile

Over the past decade, Lupin has establi shed itself as a leading generic player in India. US and India are the company’s largest markets and contribute around 37.8% and 34.2%, respectively, to the Q2FY24 sales of the company. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, across Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions. While in India, Lupin is among the top 10 and fastest-growing companies as well. The company is also among the top five companies in terms of prescriptions in the US. Therapy wise, the company has a leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastrointestinal (GI), central nervous system (CNS), and women’s health segments. In terms of manufacturing capabilities, Lupin has 15 manufacturing sites and seven research centers globally.

Investment Arguments

Focus on strengthening the respiratory portfolio Lupin is strengthening its respiratory portfolio by acquiring drugs from Sanofi. It currently acquired brands like AARANE in Germany and NALCROM in Canada after acquiring assets like Xopenex and Brovana in the US market. Lupin’s existing respiratory portfolio is gaining traction, where Albuterol is gaining market share in the generics segment at 23% and Arfomoterol market share stands at 33% in the branded generics portfolio. Recently, Lupin launched gSpiriva in the US market, which is also gaining momentum. Lupin’s strategy is to focus on complex respiratory products like inhalers and transdermal to mitigate price erosion pressure. We believe Lupin’s focus on the US portfolio to increase USD sales to above USD200 mn from the earlier range of USD170-190 mn.

Complex generics to drive US growth Lupin's shift from commoditized generics to complex generics in the US has resulted in a revenue surge, reaching US$213mn in Q2FY24. Focus on intricate products in Respiratory, Injectables, and Biosimilars positions the company for sustained growth going ahead. The company witnessed an increasing share of complex generics in its portfolio led by inhalation (>40% of sales) in Q2FY24.

Pithampur unit-2 plant clearance to open approval for ophthalmic products Lupin’s Pithampur unit-2 received EIR after being under observation from 2017 and received an OAI in 2019 by the USFDA. Lupin has 15 manufacturing units, of which only two plants have not received any clearance. Lupin’s Pithampur unit-2 is an important plant as 30-35 products are approved from Pithampur unit-2 out of 160 products. Lupin intends to launch ophthalmic products from Pithampur unit-2. Recently, Lupin received approval from USFDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2%. Lupin does not have competitors in the currently approved Loteprednol 0.2% for the US market. It had also received approval for Bromfenac Ophthalmic Solution, 0.09% (RLD Bromday). Lupin earlier had four plants, that were not cleared, mainly Mandideep unit-1, Tarapur unit, Nashik unit-1, and Somerset, but now only Mandideep unit-1 and Tarapur units are awaiting clearance.

The leading player in the Indian branded formulations segment Lupin ranks sixth in the IPM with a leading position in several therapies including anti-tuberculosis (first), respiratory (second), cardiology (third), and anti-diabetic (third). We believe that the performance of the segment is expected to improve over the next few quarters supported by integration of the ~1,000 marketing executives. Lupin continues to maintain its leadership position in chronic therapies and is expected to drive growth, going forward.

Foray into Diagnostics business to act as key growth trigger for Lupin Lupin's foray into Diagnostics in India is a strategic move, leveraging the ‘Lupin’ brand and existing doctor relationships. The asset-light model emphasizes routine tests, providing additional touchpoints with physicians. The company sees synergy between Pharmaceuticals and Diagnostics, aiming for revenue to take up to Rs.200-300 cr from the current Rs.2-3 cr. The Diagnostics business provides another touchpoint with doctors, strengthening the relationship and potentially leading to increased brand loyalty.

Launch of gSpiriva to aid in USD1 billion sales from the US market by FY2026E Lupin has received approval for gSpiriva, which was launched in the US market in Q2FY2024. It is one of the meaningful products for Lupin in the US market, where it does not face any competition. Though USFDA has not granted exclusivity approval, we do not foresee competitors until FY2026. Hence, we believe gSpiriva will not face price erosion pressure until FY2026. The launch of gSpiriva will drive US sales higher and aid in lifting EBITDA margins to 21% in FY2026E from 13% margin in FY2022.

Q2FY24 Financial Performance Lupin Ltd delivered solid earnings growth for the quarter ended Q2FY24. Consolidated net sales rose 2% YoY to Rs.4,939 cr as against Rs.4,091 cr registered in the same quarter of the corresponding fiscal driven by robust growth across most geographies. North America has grown at a strong 40% YoY and 17.4% QoQ. India business has grown at 6.8% YoY whilst EMEA grew at 24% YoY. Our API business registered a growth of 7% YOY.

Moving on to US Business - During the quarter, the US business recorded sales of $213 mn registering a growth of 34% YoY and 18% on a QoQ basis. Just to indicate the size of the ramp-up, this number was $159 mn in Q2 FY’23. This growth has been led by New Products and by also legacy products maintaining their market share.

Coming to India, the India Region Formulations business (IRF) has grown by 7% YoY. Growth excluding NLEM is 9% YoY. As per IQVIA, all key segments except for anti-diabetes, have grown faster than the market in the quarter including cardiovascular space, respiratory, gastrointestinal (GI), and gynaecology. Even in the anti-diabetes space, non in the licensed portfolio has grown at 10% vs the IPM category growth of 4.9%. Currently, the in-licensed portfolio constitutes around 13% of IRF business vs 15.5% in FY23.

The EMEA region, which constitutes the EU region business and South Africa business, has performed exceptionally well during the quarter with a strong growth of 24% YoY. Growth in the EU has been driven by the inhalation business going strong with products like Luforbec and Beclu gaining additional share and entering newer markets. EU also saw increased tender sales.

Q2 FY24 gross margins are at 65.5% which has increased 170 bps from 63.8% ex NCE income in Q1 FY24 and materially from 58.1 % in Q2 last year. This improvement was driven by multiple factors which include better product mix, lower share of in license products, commodity deflation, increased volumes, and realization of savings from a few of the cost improvement initiatives like freight. Consolidated EBITDA more than doubled to Rs.923 cr YoY.

PAT displayed remarkable growth of 278% YoY to Rs.490 cr aided by solid topline growth and robust operational performance.

R&D is at Rs.376 crores (7.6 % of sales) in Q2 FY24 as compared to Rs.338 crores at 8.0% of sales in Q2FY23. The increase in R&D YoY is on account of investment in newer platforms of biosimilars, injectables, and the like. For the full year, we expect R&D to be around INR 1,500 to INR 1,600 crs.

Net Debt at the end of the quarter stands at INR 1,806 crores which reduced from INR 2,527 crores at the end of March 2023. Gross debt has reduced by INR 720 crores during this period.

Marksans Pharma Ltd

Pharmaceuticals & Drugs - Global


Stock Info
  • BSE 524404
  • NSE MARKSANS
  • Face Value (Rs) 1
  • Equity Capital (Rs cr) 45
  • Mkt Cap (Rs cr) 9,956.01
  • 52w H/L (Rs) 224.90 - 97.45
Shareholding pattern
  • (as on 30-Jun) %
  • Promoter 43.87
  • FIIs 18.59
  • DII 3.75
  • Public & Others 33.77
Published Date August 22, 2024
Current Market Price Rs. 524.35
Rating Buy

LUPIN Buy

Marksans Pharma Ltd

Rs. 524.35

Aug 22, 2024

BSE 524404
52W high 224.90
52W low 97.45
Face Value Rs.1
Return (%) 1m 3m 12m
Absolute 17.30 33.19 100.27
Sensex 0.50 9.40 24.06
Marksans Pharma Ltd Sensex

Multiple growth levers in place; poised for rerating

Company Profile

Marksans Pharma Ltd (MPL) was incorporated as a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. in 2001. In 2003, it was spun off into a separate entity. The company is engaged in the research, manufacturing and marketing of generic pharmaceuticals products. Marksans is headquartered in Mumbai and has subsidiaries in the UK, the US, and Australia, with proprietary marketing networks in these countries. The company has four manufacturing units – one each in UK, the US, and two in India- Goa; including the recently acquired facility from Teva and research and development centres in Goa, Navi Mumbai, the UK, and the USA. The company is planning backward integration with the manufacturing of active pharmaceutical ingredients (APIs) for captive consumption and expanding its formulation capacity over FY23-FY27.

MBFSL has manufacturing units at six locations, namely Phillaur (Punjab), Tahliwal (Himachal Pradesh), Rajpura (Punjab), Greater Noida (Uttar Pradesh), Mumbai (Maharashtra), and Bengaluru (Karnataka). The company operates in the consumer segment through its network of distributors and retailers, besides supplying to export markets and catering to institutional customers. Company supplies its products to retail consumers in 26 states within India, as well as to reputed institutional customers with pan-India presence and to 64 countries across six continents.

According to Technopak Report, ‘Mrs. Bector’s Cremica’ is one of the leading biscuit brands in the premium and mid-premium segment in Punjab, Himachal Pradesh, Jammu and Kashmir and Ladakh and ‘English Oven’ is the one of the largest selling brand in the premium bakery segment in Delhi NCR, Mumbai and Bengaluru. They are the largest supplier of buns in India to reputed QSR chains such as Burger King India Limited, Connaught Plaza Restaurants Private Limited, Hardcastle Restaurants Private Limited, and Yum! Restaurants (India) Private Limited. They are also one of the largest suppliers of biscuits to Canteen Stores Department of Government of India (“CSD”) supplying in 33 locations across India and an approved and listed supplier for Indian Railways having strong presence across Railway Station Canteens and their stores in North India. It is one of the leading exporters of biscuits from India.

Investment Arguments
Marksans

OTC business key growth driver for Marksans Pharma In the OTC Business, Marksans manufactures store brands/private label manufacturing for retailers/customers and manufactures OTC products through its own label as well. Prescription (Rx) to over-the-counter (OTC) switches have been a key growth driver for the OTC industry. MPL aims to capture a significant part of the multi-billion dollar OTC opportunity. According to IQVIA, Global OTC Size in 2023 is $183 billion. Marksan’s OTC segment grew at CAGR of 17% (from FY17-FY24) Majority of revenue in OTC comes from manufacturing and selling store brands (private label manufacturing) for key retailers in key regions. Marksans is the most preferred and growing store brand low-cost manufacturing partner. Marksans is currently present in large market-size therapeutical segments in OTC -Pain Management and Analgesics, Upper Respiratory, Digestive, and Anti Allergic. The company’s focus is to create a complete product offering in these four segments.

Marksans

Diversified geographical presence The company sells its portfolio of products internationally in over 50 countries, with the majority of the revenue generated from regulated markets. The company is among the top Indian pharmaceutical companies in the US and the UK, with products in varied therapeutic segments. The US and the UK account for around 42% and 42% of the revenue, respectively. Furthermore, the company operates in Australia and New Zealand through its subsidiaries. The geographically diversified nature of revenue reduces the exposure of the company to any adverse economic slowdown in any single geography.

Planned growth strategies The company plans to gradually enhance its existing production capacity, for which it has acquired a manufacturing plant from Teva. The plant has an installed capacity to manufacture 1.50 billion tablets per annum and has approvals to manufacture products from the EU, Health Canada, and the Japanese Health Authority. MPL intends to increase the current plant’s capacity to produce 8 billion tablets annually and obtain accreditation from the US FDA. This project will be undertaken in two phases and is expected to be completed by FY27. For the initial phase (planned completion in FY24), the company has allocated around Rs.200 crore and the company plans to spend around Rs.400 crore for inorganic growth opportunities in Europe and other emerging markets, as well as routine capex. Furthermore, the company is planning backward integration through the Contract Development and Manufacturing Organisation (CDMO) approach. These initiatives are expected to be funded without any reliance on external borrowings and are likely to improve MPL’s revenue profile and aid profitability over the medium term.

Accredited manufacturing facilities The company has four manufacturing units (including one acquired from Teva) – two in India, and one each in the US and UK. All the manufacturing facilities are accredited by various health authorities of regulated markets and are well equipped for manufacturing tablets, caplets, capsules, and pellets. The Indian facilities are located in Goa. The existing Indian facility is accredited by US-FDA, UK-MHRA, Brazil- ANVISA and Australia- TGA, while the facility acquired from Teva is accredited by UKMHRA, Canada- HPFB and Japan- PMDA. The US and UK facilities are accredited by the US-FDA and UK-MHRA respectively.

Marksans

Profitability to be driven through backward integration Marksans is in the process of backward integration through manufacturing active pharmaceutical ingredients (APIs) of four major products for captive consumption. In the next two years, the company plans to achieve both backward and forward integration. We expect the EBITDA margin to improve gradually in the near term, led by a robust pipeline of new launches in the regulated markets of the US and Europe; continued demand for its existing products, and cost savings from improved sourcing due to the company’s backward-integration initiatives.

Scaling up business in North America bodes well for future growth Marksans is present in the largest markets by total OTC drugs sales and its focus is to expand the footprint. North America and Western Europe have the highest market shares. North America OTC holds around ~25% of total global sales. US and North America is key region for Marksan’s growth in coming years. The United States is one of the few Western countries where OTC medications are available through online markets such as Amazon and retail giants CVS, Walmart, Walgreens, and Target. The widespread availability of OTC medication on the shelf of retail stores and pharmacies has made the U.S. the largest OTC drug market in the world. The FDA regulates over 300,000 marketed OTC drug products in over 80 therapeutic categories ranging from acne to cold and cough and allergy medications.

Continued expansion of product pipeline MPL boasts of a strong product pipeline followed by successful launches led by continued focus on R&D. In the UK region, the company has planned 34 new filings over the next three years, and in addition, 16 products are already filed and awaiting approval. For the US region, the company has a pipeline of 32 products with 20 being oral solids, 12 being ointments and creams and within oral solids 4 are softgels. Further, MPL has 10 products in the pipeline that are expected to be launched over the course of the next 2 years under the Australia and New Zealand region. For the Rest of the world, 124 products are approved with 120 products awaiting approval and 108 products are in the pipeline.

Marksans

Q1FY25 Financial Performance Marksans Pharma delivered robust earnings growth for the quarter ended Q1FY25. Consolidated net sales experienced robust growth of 18% YoY to Rs.591 cr as compared to Rs.500 cr registered in the same quarter of the corresponding fiscal driven by new launches and an increase in our share with existing customers in our key markets. Gross Profit exhibited remarkable growth of 28% YoY to Rs.329 cr mainly on account of softening of raw material prices and a better product mix while Gross Margins expanded 420 bps at 55.7%. EBITDA surged 26% YoY to Rs.128 cr while EBITDA Margin expanded 130 bps at 21.7% on the back of improved gross margins. Higher EBITDA has led to significant growth in the PAT level which appreciated at 26% YoY to Rs.89 cr demonstrating healthy performance overall.

Other Key highlights

  • US revenues at Rs.250.9 Cr., UK and Europe revenues at Rs.251.5, Australia and New Zealand revenues at Rs.65.6 Cr., and RoW & UAE revenues at Rs.22.7 Cr.
  • Research & Development (R&D) spend at Rs.12.0 Cr., 2.0% of consolidated revenue
  • Cash from Operations at Rs.45.3 Cr. and Free Cash Flow at Rs.14.3 Cr
  • Capex incurred in the quarter is Rs.31.0 Cr.
  • Cash Balance as of 30th June 2024 is Rs. 691 Cr.
  • Received Market Authorization from UKMHRA for products Levonorgestrel 1.5mg Tablets, Rasagiline 1mg Tablets and Olmesartan 10, 20, 40mg Tablets in the quarter 
Marksans